A decision is due any day from a federal court in Texas that could have sweeping repercussions on abortion access across the country — including in states, like Maryland, where the procedure is protected. Several anti-abortion groups and doctors are suing the U.S. Food and Drug Administration to revoke its 22-year-old approval of the drug mifepristone, which is used in combination with the drug misoprostol in 98% of medication abortions in the U.S.
Maryland prepares for federal ruling that could force abortion pill off the market
March 6, 2023